- Open Access
Ultrastructural differences in pretangles between Alzheimer disease and corticobasal degeneration revealed by comparative light and electron microscopy
© Tatsumi et al.; licensee BioMed Central Ltd. 2014
- Received: 5 November 2014
- Accepted: 5 November 2014
- Published: 11 December 2014
Pretangles are defined under the light microscope as diffuse and granular tau immunoreactivity in neurons in tissue from patients with Alzheimer disease (AD) or corticobasal degeneration (CBD) and are considered to be a premature stage before neurofibrillary tangle formation. However, the ultrastructure of pretangles remains to be described. To clarify the similarities and differences between pretangles from patients with AD and CBD (AD-pretangles and CBD-pretangles, respectively), we examined cortical pretangles in tissue from patients with each of diseases. For direct light and electron microscopic (LM/EM) correlation of the pretangles, we used quantum dot nanocrystals (QDs) with dual fluorescent and electron-dense properties. We first identified tau-labeled pretangles on fluorescence LM and subsequently examined the same neurons on EM. Energy dispersive X-ray spectrometry (EDX) color mapping identified selenium (Se) and cadmium (Cd) as elementary components of QDs and highlighted each QD particle clearly against gray-scale EM images. With these methods, we were successful for the first time in demonstrating accurately that LM-defined pretangles are tau-positive straight filaments sparsely distributed throughout neuronal cytoplasm and neurites in both AD and CBD at the EM level. Notably, AD-pretangles showed a strong tendency to form fibrillary tangles even at an early stage, whereas pretangles or Pick-like inclusions in tissue from patients with CBD did not even at an advanced stage. In conclusion, AD-pretangles and CBD-pretangles showed essential differences at the EM level.
- Alzheimer Disease
- Electron Microscopy Level
- Corticobasal Degeneration
- Electron Microscopy Finding
- Electron Microscopy Section
Changes that occur in relevant molecules before they become organized into disease-specific inclusions in human brains are attracting increasing attention . The pretangle is an example of such an early change; it was originally defined under light microscopy (LM) as diffuse and granular tau immunoreactivity in the cytoplasm and neurites of otherwise intact neurons in brains from patients with Alzheimer disease (AD) -. Mature neurofibrillary tangles (NFTs), which are hallmarks of AD, are readily identified as bundles of paired helical filaments (PHFs) under electron microscopy (EM) . However, it is difficult to identify pretangles under EM because their faint tau immunoreactivity suggests that their ultrastructure is less distinct. Although putative ultrastructures of pretangles in AD have been reported, it is not yet clarified whether they really represent neurons containing diffuse and granular tau immmunoreactivity as defined under LM . Similar granular tau immunoreactivity has also been observed in corticobasal degeneration (CBD), a four-repeat tauopathy that causes degeneration of the cerebral cortex, basal ganglia, and substantia nigra. Because they appear similar to AD-pretangles under LM, this granular tau immunoreactivity is also known as pretangles. Pretangles are considered one of the most important neuronal cytopathologies in CBD , but are also found in argyrophilic grain disease or progressive supranuclear palsy .
The aim of this study was to visualize the ultrastructures of LM-defined AD- and CBD-pretangles and thereby to identify possible differences between them. For this purpose, it is necessary to directly compare LM and EM images of the same pretangle, an approach that is now named “correlative light and electron microscopy (CLEM)”. Although CLEM protocols have been developing -, they usually allow LM/EM comparisons for only small fields (the size of the EM preparation). This limitation makes it practically impossible to capture pretangles for immunoEM study because pretangles are not sufficiently frequent to be included by chance in such tiny preparations. Therefore, it is necessary to excise tissue containing a pretangle from the LM sample before it can be prepared for EM.
Quantum dots (QDs) are fluorescent, electron-dense semiconductor nanocrystals of uniform size with a core of cadmium selenide . On EM examination, QDs also display a characteristic peripheral halo . These dual optical properties allow QDs to be identified under both LM and EM and therefore permits labeled LM structures to be compared directly with their ultrastructures . Using QDs, we recently established three dimension (3D) - oriented immunoelectron microscopy ,. In this method, a thick floating section from the formalin-fixed human brain is incubated with the primary and QD-conjugated secondary antibodies. After a target neuron is examined with fluorescent LM (confocal microscopy), landmarks are punched out around the neuron using laser microdissection. Then, this floating section is processed for EM preparation. The advantage of this stepwise LM-EM approach is that the neuron of interest can be observed closely on confocal microscopy prior to the EM examination, and its EM findings can be supplemented with confocal images because the same reporter (i.e., QDs) can been seen under both LM and EM immunostaining.
Although QDs provide a powerful bridge between LM and EM, their electron density is lower and their contour is less distinct than those of gold particles, leading to doubts about QD use as an immunolabeling material for EM. We previously overcame this problem using energy dispersive X-ray (EDX) spectrometry, which demonstrated parallel peaks corresponding to selenium (Se) and cadmium (Cd) on the pixels for definitive confirmation of QDs on EM preparations . Because it is possible to obtain EDX spectrum for each pixel, we extended this pixel-based EDX analysis to plot the entire EM field pixel by pixel in this study. Operational display of pixels containing Cd peak or those containing Se peak highlighted QD particles based on their elemental composition with different colors. When it was overlaid onto the conventional gray-scale EM image, this EDX color mapping clearly distinguished QDs from background structures such as ribosomes.
With these methods, it is possible to examine the ultrastructural details of AD- and CBD-pretangles and to elucidate their similarities and differences at the EM level -,. Using this LM/EM correlation with novel mapping method, we obtained an EM image of the early stage of neuronal tau deposition in AD-pretangles and found essential differences between AD- and CBD-pretangles at the EM level. This is the first successful demonstration of their ultrastructural differences.
Alzheimer disease and corticobasal degeneration cases
Demographic features of cases with AD, normal aging, and CBD
Age of death (y)/sex
Brain weight (g)
Braak NFT stage
Type of tau-positive inclusions investigated
No history of dementia or motor symptoms
Severe dementia, disorientation
Supranuclear gaze palsy, frequent fall, parkinsonism, frontal signs
Pretangles, Pick-like inclusions*
Frontotemporal dementia, parkinsonism
Pretangles, Pick-like inclusions, ballooned neurons
Pre-embedding tau/QD labeling for LM/EM observation
Formalin-fixed brains were rinsed in phosphate-buffered saline (PBS) and cryoprotected in 20% sucrose/PBS overnight. The tissue was frozen in optimal cutting temperature (OCT) compound and cut into 25-μm-thick floating sections on a freezing microtome. The sections were immersed in 1% bovine serum albumin/PBS for 30 min and then incubated in anti-PHF tau antibody (AT8, mouse, monoclonal, 1:700; Thermo Fisher Scientific, Tokyo, Japan) for 24 hours at room temperature (RT). After washing in PBS for 30 min, sections were incubated in an anti-mouse secondary antibody conjugated to Q-dot 655 (QD 655) (goat, 1:100 to 1:800, diluted in PBS; Invitrogen, Carlsbad, CA) for 8 hours at RT. A QD 655 dilution at 1:400 (Additional file 1: Figure S1) for a CBD pretangle provided appropriate immunoEM labeling on tau-positive filaments, whereas its fluorescent signal was not intense enough to delineate subcellular details under confocal microscopy (Additional file 1: Figure S1). Therefore, the QD-labeled sections were subsequently incubated in an anti-mouse secondary antibody conjugated to Alexa 488 (goat, 1:200; Molecular Probe) for 3 hours at RT to allow more detailed LM observation. After incubation, sections were rinsed in PBS and then mounted in fluorescence-mounting medium (S3023; Dako, Glostrup, Denmark).
Confocal LM observation and EM preparation
Energy dispersive X-ray (EDX) spectrometry and elemental mapping of QDs
The EM sections were also observed under a Hitachi HD-2700 scanning transmission electron microscope (STEM, Hitachi High Technologies Corporation, Tokyo, Japan). This STEM is equipped with a cold-field emission gun and detectors that consist of bright-field, high-angle annular dark-field (HAADF) and secondary electron (SE) detectors, which distinguish different elements (Cd and Se in this experiment) based on their energy spectra on a pixel basis. This approach identifies the presence of Cd and Se in each STEM pixel. This pixel-based identification of Cd and Se is then extended to map the entire EM field to delineate the QD particles in relation to underlying ultrastructures. The STEM was operated at 200 kV and an EDX spot analysis was performed with an incident beam size of 0.2 nm and a current of 0.4 nA. The acquisition time for each pixel was 200 μsec. In the EDX mapping, the EDX analysis was performed in a 0.4 μm × 0.5 μm field, and the total acquisition time was 90 min. Pixels containing Se or Cd peaks were displayed on the EM field independently in different color channels.
EDX analysis and EDX mapping of QDs
LM findings and corresponding ultrastructures of pretangles in AD and aging
LM findings and corresponding ultrastructures of CBD-pretangles
Ultrastructure of Pick-like inclusions in small neurons in two CBD cases
Similarities and differences between AD-pretangle and CBD-pretangle
Pick like inclusion
LM findings (confocal images)
Round, frequent vacuoles
Size of neurons involved
Small- to large- sized
Small- to large- sized
Medium- to large-sized
Density of tau filaments
Arrangement of tau filaments
Irregular/regular (focal NFT formation*3)
Regular (NFT formation)
Diameter of straight filaments
About 15 nm
About 15 nm
About 15 nm
PHF (a periodicity)
Occasional (about 80 nm)
Frequent (about 80 nm)
Occasional (130–180 nm)
Among hundreds of AT8-positive neurons on confocal, 3–4 pretangles were selected in each AD and CBD case, which were 3D-reconstructed and prepared for EM observation. In addition, 3–4 Pick-like inclusions were selected in each CBD case and were processed similarly.
The name ‘ pretangle’ was originally used to describe the premature stage of NFT formation in AD -. However, in CBD, similar structures (also called ‘pretangles’) are more prevalent than NFTs in the cerebral cortex . It has been unclear whether the pretangles of CBD represent a premature stage before NFT formation and whether they are different from AD-pretangles. Because pretangles are defined only by LM findings -, it would be helpful to compare the corresponding pretangle ultrastructures between the two diseases. However, CBD pretangles in the cortex have not previously been described at the EM level -. To address this issue, we used a method of correlative light and electron microscopy with QD immunolabeling . This procedure allowed us to observe not only the features of filamentous structures of inclusions but also their intracellular distribution and relationship with cellular organellae.
Using correlated LM and EM images, we observed a distinctive EM feature of AD-pretangles: specifically, a strong tendency to form bundles as a precursor to NFTs. Even in the earliest stages of tau accumulation, small pieces of NFTs could already been seen on the background of diffuse and granular tau staining on LM (Figure 3A) ,. Correlation of the LM and EM images revealed that the granular cytoplasmic staining on LM represented straight filaments (sparsely distributed in the neuronal cytoplasm), and the small tangles represented small bundles of parallel filaments (Figure 3D). Very similar EM findings were reported by Bancher , although it remains unclear whether their EM findings really represented LM-defined pretangles or not. Because our method of 3D-oriented immunoEM not only identify pretangles on LM, it is quite sure that our immuno EM findings represent LM-identified pretangles. Moreover, it is further possible to correlates the EM plane (Figure 3C) and its exact counterpart of the corresponding LM plane (Figure 3B), even a small aggregates (Figure 3B arrow) not identifiable on 3D stack image (Figure 3A) can be examined with EM (Figure 3C) for comparison with LM at the extreme accuracy. Another feature of AD-pretangles was perinuclear accumulation of tau. Correlation with its EM counterpart showed that a small number of tau-positive 15-nm straight filaments were present around the nuclear membranes of AD-pretangles (Figure 3G-J). It has been reported that PHF or tau-like immunoreactivity may be present in close proximity to the nuclear membrane of mature NFTs in AD -, and this report is the first demonstration of tau-immunolabeled filaments around the nuclear membrane of AD-pretangles. Although intranuclear processes such as aberrant cell cycling may be related to the pathogenesis of AD ,, it is unclear how these processes are related to the perinuclear or cytoplasmic deposition of tau.
A similar approach to CBD-pretangles of the cerebral cortex revealed several findings that differed from the features of AD-pretangles and NFTs: (i) random and diffuse distribution of 14–20 nm straight filaments and (ii) paucity of PHFs and fibrillary bundle formation. These ultrastructural architectures may explain the reticular or diffuse tau immmunoreactivity of CBD-pretangles seen on LM (Figures 4 and 5). In dendrites, a small number of straight filaments were observed lying parallel to the dendritic shaft (Figure 4D), similar to the previous reports of dendritic lesions in CBD ,. Even in CBD-pretangles with abundant tau filaments, this random and diffuse distribution of straight filaments was maintained with little NFT formation (Figure 5D). Indeed, this architecture was maintained even in Pick-like inclusions, where tau filaments were randomly assembled and were composed mainly of straight filaments and, to a lesser extent, PHFs with a periodicity of 130–180 nm (Figure 6D-E). Thus, so-called CBD-pretangles are a random accumulation of tau-positive straight filaments, rarely evolving into so-called NFTs even when the filament density is increased. These findings, especially regarding the filamentous structures themselves, were similar to previous findings in CBD (15–20 nm straight filaments or PHFs with a periodicity of 120–180 nm), which were observed in Pick-like inclusions -,, ballooned neurons ,, neuronal inclusions in the brainstem ,,, or an in vivo study using CBD brains . However, this study is the first to clarify the EM structures of cortical pretangles in CBD by accurately correlating them with LM images. Authentic Pick bodies in Pick body disease were more solid than pretangles on LM, where abundant tau-positive fibrils, 15 nm in diameter, were randomly arranged without forming PHF .
In this study, we greatly enhanced the reliability of pre-embedding immunoEM using QDs. Although QDs are considered suitable for CLEM, their reliability as a reporter for ultrastructural immunolabeling has been debated. The penetration of QD labeling is reported to be limited to several micronmeters from the sample surface . However, we were successful in immunolabeling 25-μm-thick free-floating sections by increasing the incubation time with QD-conjugated secondary antibodies to 8 hr at room temperature. This procedure enabled us to label the entire thickness of floating sections with QDs so that each tau filament was sufficiently labeled (Figures 3 and 4). Consequently, confocal images and immunoEM images could be tightly correlated.
Other disadvantages of QDs are that they have a lower electron density and less distinct contours than colloidal gold for immunolabeling. We previously used EDX spot analysis with STEM to demonstrate the presence of Se and Cd on a pixel basis . This EDX spot analysis, now extended to map the entire EM field, resulted in clear visualization of the position and form of each QD particle. When the corresponding EM image was overlaid, QDs could be readily differentiated from the grayscale cellular backgrounds (e.g., ribosomes) (Figure 2). Similar elemental mapping of Cd has been reported using electron energy loss spectrography (EELS) to detect QDs in ultrathin EM samples . However, compared with EELS, EDX is more suitable for the detection of heavy metals, such as Cd or Se ,. Moreover, because EELS is performed without electron staining, it is difficult to gain sufficient contrast in EM images . Therefore, combined with pre-embedding Q-dot immunoEM and EDX mapping, the use of QDs is one of the most sensitive and distinct ultrastructural immunolabeling techniques available and might be particularly suitable for the correlation of LM/EM images.
Accurate identification of pretangles on LM, followed by EM examination of their exact counterpart was achieved through tau immunolabeling with QD, fluorescent nanocrystals, which are detectable with LM (fluorescence signal) and with EM (electron dense particles with halo). EDX spot analysis to confirm the identity of QD on EM section by showing energy peaks for Cd and Se is now extended to map the entire EM field to highlight QD particles. This improved method with EDX mapping clearly demonstrated for the first time that AD-pretangles showed a strong tendency to form fibrillary tangles even at an early stage, whereas pretangles or Pick-like inclusions in tissue from patients with CBD did not even at an advanced stage. This novel strategy is useful to clarify how molecules other than tau are organized into ultrastructures in the early stages of disease-specific lesions.
This study was supported by Grants-in-Aid for Scientific Research (JSPS KAKENHI 25430057) from the Ministry of Education, Culture, Sports, Science and Technology; a grant from the Japan Foundation for Neuroscience and Mental Health, the Mitsui Life Social Welfare Foundation, and the Tokyo Metropolitan Institute of Medical Science project ‘Mechanism for Early Diagnosis and Prevention of Parkinson’s disease; and Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan. We are grateful to Takashi Kanemura (Hitachi High-Technologies Corporation) for excellent operation of EDX spot analysis and mapping. Technical contributions by Mr. Kentaro Endo, Ms. Hiromi Kondo (Histology Center) and Ms. Ayako Nakamura (Laboratory of Structural Neuropathology) at Tokyo Metropolitan Institute of Medical Science are gratefully acknowledged.
- Ross CA, Poirier MA: Protein aggregation and neurodegenerative disease. Nat Med 2004, 10(Suppl):S10-S17. doi:10.1038/nm1066 10.1038/nm1066View ArticlePubMedGoogle Scholar
- Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM: Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res 1991, 539(1):11–18. 10.1016/0006-8993(91)90681-KView ArticlePubMedGoogle Scholar
- Braak E, Braak H, Mandelkow EM: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994, 87(6):554–567. 10.1007/BF00293315View ArticlePubMedGoogle Scholar
- Uchihara T (2014) Pretangles and neurofibrillary changes -Similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34(6):571–7, doi:10.1111/neup.12108Google Scholar
- Kidd M: Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 1963, 197: 192–193. 10.1038/197192b0View ArticlePubMedGoogle Scholar
- Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I: Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002, 61(11):935–946.View ArticlePubMedGoogle Scholar
- Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K: Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer’s disease or progressive supranuclear palsy. Acta Neuropathol 1994, 88(4):379–383. 10.1007/BF00310383View ArticlePubMedGoogle Scholar
- Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, Kakita A, Takahashi H, Yoshida M: Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol 2014, 73(1):30–38. doi:10.1097/NEN.0000000000000022 10.1097/NEN.0000000000000022View ArticlePubMedGoogle Scholar
- Watanabe S, Punge A, Hollopeter G, Willig KI, Hobson RJ, Davis MW, Hell SW, Jorgensen EM: Protein localization in electron micrographs using fluorescence nanoscopy. Nat Methods 2011, 8(1):80–84. doi:10.1038/nmeth.1537 10.1038/nmeth.1537View ArticlePubMedGoogle Scholar
- Modla S, Czymmek KJ: Correlative microscopy: a powerful tool for exploring neurological cells and tissues. Micron 2011, 42(8):773–792. doi:10.1016/j.micron.2011.07.001 10.1016/j.micron.2011.07.001View ArticlePubMedGoogle Scholar
- Jahn KA, Barton DA, Kobayashi K, Ratinac KR, Overall RL, Braet F: Correlative microscopy: providing new understanding in the biomedical and plant sciences. Micron 2012, 43(5):565–582. doi:10.1016/j.micron.2011.12.004 10.1016/j.micron.2011.12.004View ArticlePubMedGoogle Scholar
- Caplan J, Niethammer M, Taylor RM 2nd, Czymmek KJ: The power of correlative microscopy: multi-modal, multi-scale, multi-dimensional. Curr Opin Struct Biol 2011, 21(5):686–693. doi:10.1016/j.sbi.2011.06.010 10.1016/j.sbi.2011.06.010View ArticlePubMedPubMed CentralGoogle Scholar
- Giepmans BN, Deerinck TJ, Smarr BL, Jones YZ, Ellisman MH: Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots. Nat Methods 2005, 2(10):743–749. doi:10.1038/nmeth791 10.1038/nmeth791View ArticlePubMedGoogle Scholar
- Karreman MA, Agronskaia AV, van Donselaar EG, Vocking K, Fereidouni F, Humbel BM, Verrips CT, Verkleij AJ, Gerritsen HC: Optimizing immuno-labeling for correlative fluorescence and electron microscopy on a single specimen. J Struct Biol 2012, 180(2):382–386. doi:10.1016/j.jsb.2012.09.002 10.1016/j.jsb.2012.09.002View ArticlePubMedGoogle Scholar
- Deerinck TJ: The application of fluorescent quantum dots to confocal, multiphoton, and electron microscopic imaging. Toxicol Pathol 2008, 36(1):112–116. doi:10.1177/0192623307310950 10.1177/0192623307310950View ArticlePubMedPubMed CentralGoogle Scholar
- Cortese K, Diaspro A, Tacchetti C: Advanced correlative light/electron microscopy: current methods and new developments using Tokuyasu cryosections. J Histochem Cytochem 2009, 57(12):1103–1112. doi:10.1369/jhc.2009.954214 10.1369/jhc.2009.954214View ArticlePubMedPubMed CentralGoogle Scholar
- Faas FG, Barcena M, Agronskaia AV, Gerritsen HC, Moscicka KB, Diebolder CA, van Driel LF, Limpens RW, Bos E, Ravelli RB, Koning RI, Koster AJ: Localization of fluorescently labeled structures in frozen-hydrated samples using integrated light electron microscopy. J Struct Biol 2013, 181(3):283–290. doi:10.1016/j.jsb.2012.12.004 10.1016/j.jsb.2012.12.004View ArticlePubMedGoogle Scholar
- Heines MA, Guyot-Sionnest P: Synthesis and characterization of strongly luminsecing ZnS-capped CdSe nanocrystals. J Phys Chem 1996, 100: 468–471. 10.1021/jp9530562View ArticleGoogle Scholar
- Uematsu M, Adachi E, Nakamura A, Tsuchiya K, Uchihara T: Atomic identification of fluorescent Q-dots on tau-positive fibrils in 3D-reconstructed pick bodies. Am J Pathol 2012, 180(4):1394–1397. doi:10.1016/j.ajpath.2011.12.029 10.1016/j.ajpath.2011.12.029View ArticlePubMedGoogle Scholar
- Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T: Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 2012, 22(1):67–78. doi:10.1111/j.1750–3639.2011.00509.x 10.1111/j.1750-3639.2011.00509.xView ArticlePubMedGoogle Scholar
- Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT: National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 2012, 123(1):1–11. doi:10.1007/s00401–011–0910–3 10.1007/s00401-011-0910-3View ArticlePubMedGoogle Scholar
- Takahashi T, Amano N, Hanihara T, Nagatomo H, Yagishita S, Itoh Y, Yamaoka K, Toda H, Tanabe T: Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 1996, 138(1–2):66–77. 10.1016/0022-510X(95)00347-5View ArticlePubMedGoogle Scholar
- Arima K, Uesugi H, Fujita I, Sakurai Y, Oyanagi S, Andoh S, Izumiyama Y, Inose T: Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci 1994, 127(2):186–197. 10.1016/0022-510X(94)90072-8View ArticlePubMedGoogle Scholar
- Feany MB, Dickson DW: Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995, 146(6):1388–1396.PubMedPubMed CentralGoogle Scholar
- Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu WK, Yen SH, Weidenheim K, Dickson DW: Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994, 145(6):1496–1508.PubMedPubMed CentralGoogle Scholar
- Mori H, Nishimura M, Namba Y, Oda M: Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 1994, 88(2):113–121. 10.1007/BF00294503View ArticlePubMedGoogle Scholar
- Lippa CF, Smith TW, Fontneau N: Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases. J Neurol Sci 1990, 98(2–3):301–310. 10.1016/0022-510X(90)90271-NView ArticlePubMedGoogle Scholar
- Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Homma A, Homma Y, Horikawa Y, Tokiguchi S: Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 1994, 87(6):545–553. 10.1007/BF00293314View ArticlePubMedGoogle Scholar
- Kato S, Nakamura H, Otomo E: Reappraisal of neurofibrillary tangles. Immunohistochemical, ultrastructural, and immunoelectron microscopical studies. Acta Neuropathol 1989, 77(3):258–266. 10.1007/BF00687577View ArticlePubMedGoogle Scholar
- Lowe J, Mirra SS, Hyman B, Dickson DW: Histopathology of Alzheimer’s disease. In Greenfield’s neuropathology. Edited by: Love S, Louis DN, Ellison DW. Edward Arnold, London; 2008:1031–1152.Google Scholar
- Metuzals J, Robitaille Y, Houghton S, Gauthier S, Leblanc R: Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer’s disease. J Neurocytol 1988, 17(6):827–833. 10.1007/BF01216709View ArticlePubMedGoogle Scholar
- Hara M, Hirokawa K, Kamei S, Uchihara T: Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology. Acta Neuropathol 2013, 125(4):565–579. doi:10.1007/s00401–013–1097–6 10.1007/s00401-013-1097-6View ArticlePubMedGoogle Scholar
- Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P: Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 2005, 25(22):5446–5454. doi:10.1523/JNEUROSCI. 4637–04.2005 10.1523/JNEUROSCI.4637-04.2005View ArticlePubMedGoogle Scholar
- Yang Y, Geldmacher DS, Herrup K: DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci 2001, 21(8):2661–2668.PubMedGoogle Scholar
- Nisman R, Dellaire G, Ren Y, Li R, Bazett-Jones DP: Application of quantum dots as probes for correlative fluorescence, conventional, and energy-filtered transmission electron microscopy. J Histochem Cytochem 2004, 52(1):13–18. 10.1177/002215540405200102View ArticlePubMedGoogle Scholar
- Leapman RD, Ornberg RL: Quantitative electron energy loss spectroscopy in biology. Ultramicroscopy 1988, 24(2–3):251–268. 10.1016/0304-3991(88)90314-2View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.